136 related articles for article (PubMed ID: 2413861)
1. In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles).
Fry DW; Boritzki TJ; Besserer JA; Jackson RC
Biochem Pharmacol; 1985 Oct; 34(19):3499-508. PubMed ID: 2413861
[TBL] [Abstract][Full Text] [Related]
2. Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazoles.
Fry DW; Besserer JA
Mol Pharmacol; 1988 Jan; 33(1):84-92. PubMed ID: 2447481
[TBL] [Abstract][Full Text] [Related]
3. Design, biochemical pharmacology, electrochemistry and tumour biology of anti-tumour anthrapyrazoles.
Showalter HD; Fry DW; Leopold WR; Lown JW; Plambeck JA; Reszka K
Anticancer Drug Des; 1986 Apr; 1(2):73-85. PubMed ID: 2453196
[TBL] [Abstract][Full Text] [Related]
4. The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity.
Jackson RC; Fry DW; Boritzki TJ; Roberts BJ; Hook KE; Leopold WR
Adv Enzyme Regul; 1985; 23():193-215. PubMed ID: 3840949
[TBL] [Abstract][Full Text] [Related]
5. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
Leopold WR; Nelson JM; Plowman J; Jackson RC
Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M
Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistance.
Ganapathi R; Grabowski D
Biochem Pharmacol; 1988 Jan; 37(2):185-93. PubMed ID: 3342075
[TBL] [Abstract][Full Text] [Related]
8. Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide in L1210 murine leukemia cells.
Zwelling LA; Kerrigan D; Marton LJ
Cancer Res; 1985 Mar; 45(3):1122-6. PubMed ID: 2982483
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
Baguley BC; Denny WA; Atwell GJ; Finlay GJ; Rewcastle GW; Twigden SJ; Wilson WR
Cancer Res; 1984 Aug; 44(8):3245-51. PubMed ID: 6547635
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization.
Hartley JA; Reszka K; Zuo ET; Wilson WD; Morgan AR; Lown JW
Mol Pharmacol; 1988 Mar; 33(3):265-71. PubMed ID: 3352592
[TBL] [Abstract][Full Text] [Related]
11. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
12. Studies on the biochemical mechanism of the novel antitumor agent, CI-920.
Fry DW; Boritzki TJ; Jackson RC
Cancer Chemother Pharmacol; 1984; 13(3):171-5. PubMed ID: 6548419
[TBL] [Abstract][Full Text] [Related]
13. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
Chou TC; Schmid FA; Feinberg A; Philips FS; Han J
Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
[TBL] [Abstract][Full Text] [Related]
14. Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents.
Pommier Y; Schwartz RE; Kohn KW; Zwelling LA
Biochemistry; 1984 Jul; 23(14):3194-201. PubMed ID: 6087890
[TBL] [Abstract][Full Text] [Related]
15. The effects of alpha-methylene-gamma-lactone purines and pyrimidines on L1210 lymphoid leukemia nucleic acid metabolism.
Hall IH; Lee KH
Anticancer Res; 1991; 11(1):337-42. PubMed ID: 2018369
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of mitoxantrone: mode of action and pharmacokinetics.
Alberts DS; Peng YM; Bowden GT; Dalton WS; Mackel C
Invest New Drugs; 1985; 3(2):101-7. PubMed ID: 4040505
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids.
Kapuscinski J; Darzynkiewicz Z
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6302-6. PubMed ID: 3462696
[TBL] [Abstract][Full Text] [Related]
18. Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells.
Jensen CG; Wilson WR; Bleumink AR
Cancer Res; 1985 Feb; 45(2):717-25. PubMed ID: 3838148
[TBL] [Abstract][Full Text] [Related]
19. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
[TBL] [Abstract][Full Text] [Related]
20. Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.
Pommier Y; Minford JK; Schwartz RE; Zwelling LA; Kohn KW
Biochemistry; 1985 Nov; 24(23):6410-6. PubMed ID: 3002440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
